Showing results (311-320 of 1,657) with videos related to

Sort By:
Pageof 166
BMC Cancer|November 11, 2015
Genomic profiling of CHEK2*1100delC-mutated breast carcinomasMaarten P G Massink, Irsan E Kooi, John W M Martens, et al.
Thrombosis and Haemostasis|December 30, 1998
A plasma coagulation assay for an activated protein C-independent anticoagulant activity of protein SM van Wijnen, C van 't Veer, J C Meijers, et al.
British Journal of Haematology|July 26, 2002
Protein C inhibitor (plasminogen activator inhibitor-3) and the risk of venous thrombosisJoost C M Meijers, J Arnoud Marquart, Rogier M Bertina, et al.
British Journal of Industrial Medicine|August 1, 1989
Prenarcotic and neuraesthenic symptoms among Dutch workers exposed to organic solventsC van Vliet, G M Swaen, J M Meijers, et al.
European Journal of Pharmacology|June 24, 2015
Galectin-3 and post-myocardial infarction cardiac remodelingWouter C Meijers, A Rogier van der Velde, Domingo A Pascual-Figal, et al.
Journal of Thrombosis and Haemostasis : JTH|July 15, 2018
Factor XI promotes hemostasis in factor IX-deficient miceB M Mohammed, Q Cheng, A Matafonov, et al.
The Journal of Biological Chemistry|June 8, 2007
Thrombin-activatable fibrinolysis inhibitor binds to Streptococcus pyogenes by interacting with collagen-like proteins A and BLisa I Påhlman, Pauline F Marx, Matthias Mörgelin, et al.
Journal of Thrombosis and Haemostasis : JTH|August 14, 2010
Thrombin-activatable fibrinolysis inhibitor is degraded by Salmonella enterica and Yersinia pestisM Valls Serón, J Haiko, P G DE Groot, et al.
The Journal of Clinical Investigation|May 15, 1997
Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysisP A Von dem Borne, L Bajzar, J C Meijers, et al.
Pageof 166